HEADER HYDROLASE 04-OCT-04 1XMU TITLE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH TITLE 2 ROFLUMILAST COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B; COMPND 5 SYNONYM: DPDE4, PDE32; COMPND 6 EC: 3.1.4.17; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B; COMPND 12 SYNONYM: DPDE4, PDE32; COMPND 13 EC: 3.1.4.17; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDE4B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON PLUS(RIL); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: PDE4B; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON PLUS(RIL); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS PHOSPHODIESTERASE, PDE, PDE4B, ROFLUMILAST, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU, AUTHOR 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG,M.V.MILBURN, AUTHOR 3 S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG REVDAT 4 13-JUL-11 1XMU 1 VERSN REVDAT 3 06-OCT-09 1XMU 1 HETNAM REVDAT 2 24-FEB-09 1XMU 1 VERSN REVDAT 1 14-DEC-04 1XMU 0 JRNL AUTH G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU, JRNL AUTH 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG, JRNL AUTH 3 M.V.MILBURN,S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG JRNL TITL STRUCTURAL BASIS FOR THE ACTIVITY OF DRUGS THAT INHIBIT JRNL TITL 2 PHOSPHODIESTERASES. JRNL REF STRUCTURE V. 12 2233 2004 JRNL REFN ISSN 0969-2126 JRNL PMID 15576036 JRNL DOI 10.1016/J.STR.2004.10.004 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.25 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 35524 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1874 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2660 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2850 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5307 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 79 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.25000 REMARK 3 B22 (A**2) : 1.71000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.316 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.232 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.161 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.722 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5474 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4836 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7421 ; 1.394 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11268 ; 1.048 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 652 ; 3.034 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 837 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6052 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1081 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1286 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5460 ; 0.217 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3051 ; 0.099 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 126 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.072 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.161 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 41 ; 0.320 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3267 ; 0.581 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5299 ; 1.139 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2207 ; 1.776 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2116 ; 2.967 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 155 A 193 REMARK 3 RESIDUE RANGE : A 195 A 431 REMARK 3 RESIDUE RANGE : A 433 A 485 REMARK 3 ORIGIN FOR THE GROUP (A): 1.8541 2.6796 53.0128 REMARK 3 T TENSOR REMARK 3 T11: 0.1505 T22: 0.0916 REMARK 3 T33: 0.1132 T12: -0.0223 REMARK 3 T13: 0.0279 T23: 0.0078 REMARK 3 L TENSOR REMARK 3 L11: 1.4714 L22: 0.3800 REMARK 3 L33: 1.3845 L12: 0.1279 REMARK 3 L13: 0.0130 L23: 0.1402 REMARK 3 S TENSOR REMARK 3 S11: -0.0051 S12: 0.0684 S13: -0.1660 REMARK 3 S21: 0.1236 S22: -0.0695 S23: -0.0052 REMARK 3 S31: 0.0461 S32: -0.1191 S33: 0.0746 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 163 B 193 REMARK 3 RESIDUE RANGE : B 195 B 319 REMARK 3 RESIDUE RANGE : B 321 B 485 REMARK 3 ORIGIN FOR THE GROUP (A): 42.3709 2.5940 52.3363 REMARK 3 T TENSOR REMARK 3 T11: 0.1233 T22: 0.0672 REMARK 3 T33: 0.1331 T12: 0.0081 REMARK 3 T13: 0.0336 T23: 0.0931 REMARK 3 L TENSOR REMARK 3 L11: 1.9391 L22: 0.3214 REMARK 3 L33: 1.8784 L12: -0.4174 REMARK 3 L13: -0.3886 L23: 0.1645 REMARK 3 S TENSOR REMARK 3 S11: -0.0012 S12: 0.0215 S13: -0.1012 REMARK 3 S21: -0.0574 S22: -0.1020 S23: 0.0054 REMARK 3 S31: 0.0128 S32: 0.1470 S33: 0.1032 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XMU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-NOV-04. REMARK 100 THE RCSB ID CODE IS RCSB030528. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 10 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BLU-ICE REMARK 200 DATA SCALING SOFTWARE : ELVES REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35524 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 70.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.56800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE AND LITHIUM SULFATE , REMARK 280 PH 10, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.65800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.01300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.01300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.65800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS ONE MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 131 REMARK 465 GLY A 132 REMARK 465 SER A 133 REMARK 465 SER A 134 REMARK 465 HIS A 135 REMARK 465 HIS A 136 REMARK 465 HIS A 137 REMARK 465 HIS A 138 REMARK 465 HIS A 139 REMARK 465 HIS A 140 REMARK 465 SER A 141 REMARK 465 SER A 142 REMARK 465 GLY A 143 REMARK 465 LEU A 144 REMARK 465 VAL A 145 REMARK 465 PRO A 146 REMARK 465 ARG A 147 REMARK 465 GLY A 148 REMARK 465 SER A 149 REMARK 465 HIS A 150 REMARK 465 MET A 151 REMARK 465 SER A 152 REMARK 465 ILE A 153 REMARK 465 SER A 154 REMARK 465 GLN A 486 REMARK 465 SER A 487 REMARK 465 PRO A 488 REMARK 465 SER A 489 REMARK 465 PRO A 490 REMARK 465 PRO A 491 REMARK 465 LEU A 492 REMARK 465 ASP A 493 REMARK 465 GLU A 494 REMARK 465 GLN A 495 REMARK 465 ASN A 496 REMARK 465 ARG A 497 REMARK 465 ASP A 498 REMARK 465 CYS A 499 REMARK 465 GLN A 500 REMARK 465 GLY A 501 REMARK 465 LEU A 502 REMARK 465 MET A 503 REMARK 465 GLU A 504 REMARK 465 LYS A 505 REMARK 465 PHE A 506 REMARK 465 GLN A 507 REMARK 465 PHE A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 THR A 511 REMARK 465 LEU A 512 REMARK 465 ASP A 513 REMARK 465 GLU A 514 REMARK 465 GLU A 515 REMARK 465 ASP A 516 REMARK 465 SER A 517 REMARK 465 GLU A 518 REMARK 465 GLY A 519 REMARK 465 PRO A 520 REMARK 465 GLU A 521 REMARK 465 LYS A 522 REMARK 465 GLU A 523 REMARK 465 GLY A 524 REMARK 465 GLU A 525 REMARK 465 GLY A 526 REMARK 465 HIS A 527 REMARK 465 SER A 528 REMARK 465 MET B 131 REMARK 465 GLY B 132 REMARK 465 SER B 133 REMARK 465 SER B 134 REMARK 465 HIS B 135 REMARK 465 HIS B 136 REMARK 465 HIS B 137 REMARK 465 HIS B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 465 SER B 141 REMARK 465 SER B 142 REMARK 465 GLY B 143 REMARK 465 LEU B 144 REMARK 465 VAL B 145 REMARK 465 PRO B 146 REMARK 465 ARG B 147 REMARK 465 GLY B 148 REMARK 465 SER B 149 REMARK 465 HIS B 150 REMARK 465 MET B 151 REMARK 465 SER B 152 REMARK 465 ILE B 153 REMARK 465 SER B 154 REMARK 465 ARG B 155 REMARK 465 PHE B 156 REMARK 465 GLY B 157 REMARK 465 VAL B 158 REMARK 465 ASN B 159 REMARK 465 THR B 160 REMARK 465 GLU B 161 REMARK 465 ASN B 162 REMARK 465 GLN B 486 REMARK 465 SER B 487 REMARK 465 PRO B 488 REMARK 465 SER B 489 REMARK 465 PRO B 490 REMARK 465 PRO B 491 REMARK 465 LEU B 492 REMARK 465 ASP B 493 REMARK 465 GLU B 494 REMARK 465 GLN B 495 REMARK 465 ASN B 496 REMARK 465 ARG B 497 REMARK 465 ASP B 498 REMARK 465 CYS B 499 REMARK 465 GLN B 500 REMARK 465 GLY B 501 REMARK 465 LEU B 502 REMARK 465 MET B 503 REMARK 465 GLU B 504 REMARK 465 LYS B 505 REMARK 465 PHE B 506 REMARK 465 GLN B 507 REMARK 465 PHE B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 465 THR B 511 REMARK 465 LEU B 512 REMARK 465 ASP B 513 REMARK 465 GLU B 514 REMARK 465 GLU B 515 REMARK 465 ASP B 516 REMARK 465 SER B 517 REMARK 465 GLU B 518 REMARK 465 GLY B 519 REMARK 465 PRO B 520 REMARK 465 GLU B 521 REMARK 465 LYS B 522 REMARK 465 GLU B 523 REMARK 465 GLY B 524 REMARK 465 GLU B 525 REMARK 465 GLY B 526 REMARK 465 HIS B 527 REMARK 465 SER B 528 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 230 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP A 256 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 392 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 375 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 CYS B 390 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 ASP B 419 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 159 150.82 -49.24 REMARK 500 GLU A 163 -71.57 -33.58 REMARK 500 CME A 194 -71.17 -25.50 REMARK 500 ASP A 299 7.45 57.15 REMARK 500 SER A 301 55.82 38.37 REMARK 500 ILE A 450 -57.21 -133.19 REMARK 500 GLN A 463 126.33 -36.42 REMARK 500 SER B 187 33.59 -146.99 REMARK 500 SER B 301 57.15 36.09 REMARK 500 HIS B 319 23.51 -75.08 REMARK 500 CME B 320 -12.06 -152.51 REMARK 500 ASP B 321 92.20 -68.05 REMARK 500 SER B 368 34.89 -82.90 REMARK 500 SER B 369 15.26 -148.87 REMARK 500 ASP B 375 50.72 -109.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 HOH 1003-1009 ARE ASSOCIATED WITH CHAIN A. REMARK 600 HOH 2003-20010 ARE ASSOCIATED WITH CHAIN B. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 238 NE2 REMARK 620 2 HIS A 274 NE2 101.3 REMARK 620 3 ASP A 275 OD2 90.3 88.3 REMARK 620 4 ASP A 392 OD2 91.1 88.1 176.4 REMARK 620 5 HOH A1007 O 166.5 89.7 82.3 97.0 REMARK 620 6 HOH A1008 O 87.6 169.5 97.2 86.2 82.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 275 OD1 REMARK 620 2 HOH A1006 O 92.3 REMARK 620 3 HOH A 8 O 162.7 101.2 REMARK 620 4 HOH A1007 O 89.5 91.3 100.8 REMARK 620 5 HOH A1004 O 88.1 178.0 78.1 90.7 REMARK 620 6 HOH A1005 O 86.8 87.1 83.2 176.0 90.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 238 NE2 REMARK 620 2 HIS B 274 NE2 102.9 REMARK 620 3 ASP B 275 OD2 82.8 90.4 REMARK 620 4 ASP B 392 OD2 92.2 93.6 174.2 REMARK 620 5 HOH B2008 O 162.5 92.6 89.0 95.0 REMARK 620 6 HOH B2009 O 78.6 176.1 86.3 89.9 85.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 275 OD1 REMARK 620 2 HOH B2003 O 85.3 REMARK 620 3 HOH B2004 O 87.2 89.7 REMARK 620 4 HOH B2005 O 157.4 75.9 80.4 REMARK 620 5 HOH B2008 O 99.2 172.9 95.9 100.8 REMARK 620 6 HOH B2006 O 95.2 81.4 170.6 94.2 92.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROF A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROF B 102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XLX RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH CILOMILAST REMARK 900 RELATED ID: 1XLZ RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH FILAMINAST REMARK 900 RELATED ID: 1XM4 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH PICLAMILAST REMARK 900 RELATED ID: 1XM6 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R)-MESOPRAM REMARK 900 RELATED ID: 1XMY RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R)-ROLIPRAM REMARK 900 RELATED ID: 1XN0 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R,S)-ROLIPRAM REMARK 900 RELATED ID: 1XOM RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH CILOMILAST REMARK 900 RELATED ID: 1XON RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH PICLAMILAST REMARK 900 RELATED ID: 1XOQ RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH ROFLUMILAST REMARK 900 RELATED ID: 1XOR RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH ZARDAVERINE REMARK 900 RELATED ID: 1XOS RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH SILDENAFIL REMARK 900 RELATED ID: 1XOT RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH VARDENAFIL REMARK 900 RELATED ID: 1XOZ RELATED DB: PDB REMARK 900 PDE5A IN COMPLEX WITH TADALAFIL REMARK 900 RELATED ID: 1XP0 RELATED DB: PDB REMARK 900 PDE5A IN COMPLEX WITH VARDENAFIL DBREF 1XMU A 152 528 UNP Q07343 PDE4B_HUMAN 324 700 DBREF 1XMU B 152 528 UNP Q07343 PDE4B_HUMAN 324 700 SEQADV 1XMU MET A 131 UNP Q07343 INITIATING METHIONINE SEQADV 1XMU GLY A 132 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 133 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 134 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS A 135 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 136 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 137 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 138 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 139 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 140 UNP Q07343 EXPRESSION TAG SEQADV 1XMU SER A 141 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 142 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY A 143 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU LEU A 144 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU VAL A 145 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU PRO A 146 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU ARG A 147 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY A 148 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 149 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS A 150 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU MET A 151 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU MET B 131 UNP Q07343 INITIATING METHIONINE SEQADV 1XMU GLY B 132 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 133 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 134 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS B 135 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 136 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 137 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 138 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 139 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 140 UNP Q07343 EXPRESSION TAG SEQADV 1XMU SER B 141 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 142 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY B 143 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU LEU B 144 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU VAL B 145 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU PRO B 146 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU ARG B 147 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY B 148 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 149 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS B 150 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU MET B 151 UNP Q07343 CLONING ARTIFACT SEQRES 1 A 398 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 398 LEU VAL PRO ARG GLY SER HIS MET SER ILE SER ARG PHE SEQRES 3 A 398 GLY VAL ASN THR GLU ASN GLU ASP HIS LEU ALA LYS GLU SEQRES 4 A 398 LEU GLU ASP LEU ASN LYS TRP GLY LEU ASN ILE PHE ASN SEQRES 5 A 398 VAL ALA GLY TYR SER HIS ASN ARG PRO LEU THR CME ILE SEQRES 6 A 398 MET TYR ALA ILE PHE GLN GLU ARG ASP LEU LEU LYS THR SEQRES 7 A 398 PHE ARG ILE SER SER ASP THR PHE ILE THR TYR MET MET SEQRES 8 A 398 THR LEU GLU ASP HIS TYR HIS SER ASP VAL ALA TYR HIS SEQRES 9 A 398 ASN SER LEU HIS ALA ALA ASP VAL ALA GLN SER THR HIS SEQRES 10 A 398 VAL LEU LEU SER THR PRO ALA LEU ASP ALA VAL PHE THR SEQRES 11 A 398 ASP LEU GLU ILE LEU ALA ALA ILE PHE ALA ALA ALA ILE SEQRES 12 A 398 HIS ASP VAL ASP HIS PRO GLY VAL SER ASN GLN PHE LEU SEQRES 13 A 398 ILE ASN THR ASN SER GLU LEU ALA LEU MET TYR ASN ASP SEQRES 14 A 398 GLU SER VAL LEU GLU ASN HIS HIS LEU ALA VAL GLY PHE SEQRES 15 A 398 LYS LEU LEU GLN GLU GLU HIS CYS ASP ILE PHE MET ASN SEQRES 16 A 398 LEU THR LYS LYS GLN ARG GLN THR LEU ARG LYS MET VAL SEQRES 17 A 398 ILE ASP MET VAL LEU ALA THR ASP MET SER LYS HIS MET SEQRES 18 A 398 SER LEU LEU ALA ASP LEU LYS THR MET VAL GLU THR LYS SEQRES 19 A 398 LYS VAL THR SER SER GLY VAL LEU LEU LEU ASP ASN TYR SEQRES 20 A 398 THR ASP ARG ILE GLN VAL LEU ARG ASN MET VAL HIS CYS SEQRES 21 A 398 ALA ASP LEU SER ASN PRO THR LYS SER LEU GLU LEU TYR SEQRES 22 A 398 ARG GLN TRP THR ASP ARG ILE MET GLU GLU PHE PHE GLN SEQRES 23 A 398 GLN GLY ASP LYS GLU ARG GLU ARG GLY MET GLU ILE SER SEQRES 24 A 398 PRO MET CME ASP LYS HIS THR ALA SER VAL GLU LYS SER SEQRES 25 A 398 GLN VAL GLY PHE ILE ASP TYR ILE VAL HIS PRO LEU TRP SEQRES 26 A 398 GLU THR TRP ALA ASP LEU VAL GLN PRO ASP ALA GLN ASP SEQRES 27 A 398 ILE LEU ASP THR LEU GLU ASP ASN ARG ASN TRP TYR GLN SEQRES 28 A 398 SER MET ILE PRO GLN SER PRO SER PRO PRO LEU ASP GLU SEQRES 29 A 398 GLN ASN ARG ASP CYS GLN GLY LEU MET GLU LYS PHE GLN SEQRES 30 A 398 PHE GLU LEU THR LEU ASP GLU GLU ASP SER GLU GLY PRO SEQRES 31 A 398 GLU LYS GLU GLY GLU GLY HIS SER SEQRES 1 B 398 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 398 LEU VAL PRO ARG GLY SER HIS MET SER ILE SER ARG PHE SEQRES 3 B 398 GLY VAL ASN THR GLU ASN GLU ASP HIS LEU ALA LYS GLU SEQRES 4 B 398 LEU GLU ASP LEU ASN LYS TRP GLY LEU ASN ILE PHE ASN SEQRES 5 B 398 VAL ALA GLY TYR SER HIS ASN ARG PRO LEU THR CME ILE SEQRES 6 B 398 MET TYR ALA ILE PHE GLN GLU ARG ASP LEU LEU LYS THR SEQRES 7 B 398 PHE ARG ILE SER SER ASP THR PHE ILE THR TYR MET MET SEQRES 8 B 398 THR LEU GLU ASP HIS TYR HIS SER ASP VAL ALA TYR HIS SEQRES 9 B 398 ASN SER LEU HIS ALA ALA ASP VAL ALA GLN SER THR HIS SEQRES 10 B 398 VAL LEU LEU SER THR PRO ALA LEU ASP ALA VAL PHE THR SEQRES 11 B 398 ASP LEU GLU ILE LEU ALA ALA ILE PHE ALA ALA ALA ILE SEQRES 12 B 398 HIS ASP VAL ASP HIS PRO GLY VAL SER ASN GLN PHE LEU SEQRES 13 B 398 ILE ASN THR ASN SER GLU LEU ALA LEU MET TYR ASN ASP SEQRES 14 B 398 GLU SER VAL LEU GLU ASN HIS HIS LEU ALA VAL GLY PHE SEQRES 15 B 398 LYS LEU LEU GLN GLU GLU HIS CME ASP ILE PHE MET ASN SEQRES 16 B 398 LEU THR LYS LYS GLN ARG GLN THR LEU ARG LYS MET VAL SEQRES 17 B 398 ILE ASP MET VAL LEU ALA THR ASP MET SER LYS HIS MET SEQRES 18 B 398 SER LEU LEU ALA ASP LEU LYS THR MET VAL GLU THR LYS SEQRES 19 B 398 LYS VAL THR SER SER GLY VAL LEU LEU LEU ASP ASN TYR SEQRES 20 B 398 THR ASP ARG ILE GLN VAL LEU ARG ASN MET VAL HIS CYS SEQRES 21 B 398 ALA ASP LEU SER ASN PRO THR LYS SER LEU GLU LEU TYR SEQRES 22 B 398 ARG GLN TRP THR ASP ARG ILE MET GLU GLU PHE PHE GLN SEQRES 23 B 398 GLN GLY ASP LYS GLU ARG GLU ARG GLY MET GLU ILE SER SEQRES 24 B 398 PRO MET CYS ASP LYS HIS THR ALA SER VAL GLU LYS SER SEQRES 25 B 398 GLN VAL GLY PHE ILE ASP TYR ILE VAL HIS PRO LEU TRP SEQRES 26 B 398 GLU THR TRP ALA ASP LEU VAL GLN PRO ASP ALA GLN ASP SEQRES 27 B 398 ILE LEU ASP THR LEU GLU ASP ASN ARG ASN TRP TYR GLN SEQRES 28 B 398 SER MET ILE PRO GLN SER PRO SER PRO PRO LEU ASP GLU SEQRES 29 B 398 GLN ASN ARG ASP CYS GLN GLY LEU MET GLU LYS PHE GLN SEQRES 30 B 398 PHE GLU LEU THR LEU ASP GLU GLU ASP SER GLU GLY PRO SEQRES 31 B 398 GLU LYS GLU GLY GLU GLY HIS SER MODRES 1XMU CME A 194 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1XMU CME A 432 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1XMU CME B 194 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1XMU CME B 320 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 194 10 HET CME A 432 10 HET CME B 194 10 HET CME B 320 10 HET ZN A1001 1 HET MG A1002 1 HET ZN B1001 1 HET MG B1002 1 HET ROF A 101 26 HET ROF B 102 26 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM ZN ZINC ION HETNAM MG MAGNESIUM ION HETNAM ROF 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4- HETNAM 2 ROF (DIFLUOROMETHOXY)BENZAMIDE HETSYN ROF ROFLUMILAST FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 3 ZN 2(ZN 2+) FORMUL 4 MG 2(MG 2+) FORMUL 7 ROF 2(C17 H14 CL2 F2 N2 O3) FORMUL 9 HOH *79(H2 O) HELIX 1 1 ASN A 162 LEU A 170 1 9 HELIX 2 2 GLU A 171 LEU A 173 5 3 HELIX 3 3 ASN A 179 SER A 187 1 9 HELIX 4 4 ARG A 190 ARG A 203 1 14 HELIX 5 5 ASP A 204 PHE A 209 1 6 HELIX 6 6 SER A 212 ASP A 225 1 14 HELIX 7 7 ASN A 235 SER A 251 1 17 HELIX 8 8 THR A 252 ASP A 256 5 5 HELIX 9 9 THR A 260 HIS A 274 1 15 HELIX 10 10 SER A 282 THR A 289 1 8 HELIX 11 11 SER A 291 ASN A 298 1 8 HELIX 12 12 SER A 301 LEU A 314 1 14 HELIX 13 13 LEU A 315 GLN A 316 5 2 HELIX 14 14 GLU A 317 ASP A 321 5 5 HELIX 15 15 THR A 327 ALA A 344 1 18 HELIX 16 16 THR A 345 SER A 348 5 4 HELIX 17 17 LYS A 349 THR A 363 1 15 HELIX 18 18 ASN A 376 LEU A 393 1 18 HELIX 19 19 SER A 394 LYS A 398 5 5 HELIX 20 20 SER A 399 ARG A 424 1 26 HELIX 21 21 SER A 429 ASP A 433 5 5 HELIX 22 22 SER A 438 ILE A 450 1 13 HELIX 23 23 ILE A 450 VAL A 462 1 13 HELIX 24 24 ALA A 466 SER A 482 1 17 HELIX 25 25 GLU B 163 LEU B 170 1 8 HELIX 26 26 GLU B 171 LEU B 173 5 3 HELIX 27 27 ASN B 179 TYR B 186 1 8 HELIX 28 28 ARG B 190 ARG B 203 1 14 HELIX 29 29 ASP B 204 PHE B 209 1 6 HELIX 30 30 SER B 212 HIS B 226 1 15 HELIX 31 31 ASN B 235 SER B 251 1 17 HELIX 32 32 THR B 252 ASP B 256 5 5 HELIX 33 33 THR B 260 HIS B 274 1 15 HELIX 34 34 SER B 282 THR B 289 1 8 HELIX 35 35 SER B 291 TYR B 297 1 7 HELIX 36 36 SER B 301 LEU B 314 1 14 HELIX 37 37 THR B 327 ALA B 344 1 18 HELIX 38 38 THR B 345 SER B 348 5 4 HELIX 39 39 LYS B 349 THR B 363 1 15 HELIX 40 40 ASN B 376 LEU B 393 1 18 HELIX 41 41 SER B 394 LYS B 398 5 5 HELIX 42 42 SER B 399 ARG B 424 1 26 HELIX 43 43 SER B 429 ASP B 433 5 5 HELIX 44 44 SER B 438 ILE B 450 1 13 HELIX 45 45 ILE B 450 VAL B 462 1 13 HELIX 46 46 ALA B 466 SER B 482 1 17 LINK C THR A 193 N CME A 194 1555 1555 1.32 LINK C CME A 194 N ILE A 195 1555 1555 1.35 LINK C MET A 431 N CME A 432 1555 1555 1.33 LINK C CME A 432 N ASP A 433 1555 1555 1.35 LINK C THR B 193 N CME B 194 1555 1555 1.31 LINK C CME B 194 N ILE B 195 1555 1555 1.35 LINK C HIS B 319 N CME B 320 1555 1555 1.34 LINK C CME B 320 N ASP B 321 1555 1555 1.34 LINK NE2 HIS A 238 ZN ZN A1001 1555 1555 2.16 LINK NE2 HIS A 274 ZN ZN A1001 1555 1555 2.14 LINK OD1 ASP A 275 MG MG A1002 1555 1555 2.11 LINK OD2 ASP A 275 ZN ZN A1001 1555 1555 2.17 LINK OD2 ASP A 392 ZN ZN A1001 1555 1555 2.16 LINK NE2 HIS B 238 ZN ZN B1001 1555 1555 2.20 LINK NE2 HIS B 274 ZN ZN B1001 1555 1555 2.10 LINK OD1 ASP B 275 MG MG B1002 1555 1555 2.06 LINK OD2 ASP B 275 ZN ZN B1001 1555 1555 2.15 LINK OD2 ASP B 392 ZN ZN B1001 1555 1555 2.26 LINK ZN ZN A1001 O HOH A1007 1555 1555 2.05 LINK ZN ZN A1001 O HOH A1008 1555 1555 2.35 LINK MG MG A1002 O HOH A1006 1555 1555 2.21 LINK MG MG A1002 O HOH A 8 1555 1555 2.15 LINK MG MG A1002 O HOH A1007 1555 1555 2.10 LINK MG MG A1002 O HOH A1004 1555 1555 2.05 LINK MG MG A1002 O HOH A1005 1555 1555 2.11 LINK ZN ZN B1001 O HOH B2008 1555 1555 2.14 LINK ZN ZN B1001 O HOH B2009 1555 1555 2.31 LINK MG MG B1002 O HOH B2003 1555 1555 2.10 LINK MG MG B1002 O HOH B2004 1555 1555 2.03 LINK MG MG B1002 O HOH B2005 1555 1555 2.28 LINK MG MG B1002 O HOH B2008 1555 1555 1.92 LINK MG MG B1002 O HOH B2006 1555 1555 2.07 CISPEP 1 GLN A 463 PRO A 464 0 1.63 CISPEP 2 GLN B 463 PRO B 464 0 0.96 SITE 1 AC1 6 HIS A 238 HIS A 274 ASP A 275 ASP A 392 SITE 2 AC1 6 HOH A1007 HOH A1008 SITE 1 AC2 6 HOH A 8 ASP A 275 HOH A1004 HOH A1005 SITE 2 AC2 6 HOH A1006 HOH A1007 SITE 1 AC3 7 HIS B 238 HIS B 274 ASP B 275 ASP B 392 SITE 2 AC3 7 MG B1002 HOH B2008 HOH B2009 SITE 1 AC4 7 ASP B 275 ZN B1001 HOH B2003 HOH B2004 SITE 2 AC4 7 HOH B2005 HOH B2006 HOH B2008 SITE 1 AC5 17 HOH A 8 HOH A 28 HIS A 234 THR A 345 SITE 2 AC5 17 MET A 347 ASP A 392 LEU A 393 ASN A 395 SITE 3 AC5 17 PRO A 396 TYR A 403 TRP A 406 THR A 407 SITE 4 AC5 17 ILE A 410 MET A 411 GLN A 443 PHE A 446 SITE 5 AC5 17 HOH A1006 SITE 1 AC6 17 HOH B 21 HIS B 234 THR B 345 MET B 347 SITE 2 AC6 17 ASP B 392 LEU B 393 ASN B 395 TYR B 403 SITE 3 AC6 17 TRP B 406 THR B 407 ILE B 410 MET B 411 SITE 4 AC6 17 MET B 431 SER B 442 GLN B 443 PHE B 446 SITE 5 AC6 17 HOH B2010 CRYST1 89.316 94.100 108.026 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011196 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010627 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009257 0.00000